These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 35060714)

  • 1. Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity.
    Olson DE
    Biochemistry; 2022 Feb; 61(3):127-136. PubMed ID: 35060714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors.
    Vargas MV; Dunlap LE; Dong C; Carter SJ; Tombari RJ; Jami SA; Cameron LP; Patel SD; Hennessey JJ; Saeger HN; McCorvy JD; Gray JA; Tian L; Olson DE
    Science; 2023 Feb; 379(6633):700-706. PubMed ID: 36795823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards an understanding of psychedelic-induced neuroplasticity.
    Calder AE; Hasler G
    Neuropsychopharmacology; 2023 Jan; 48(1):104-112. PubMed ID: 36123427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelics Promote Structural and Functional Neural Plasticity.
    Ly C; Greb AC; Cameron LP; Wong JM; Barragan EV; Wilson PC; Burbach KF; Soltanzadeh Zarandi S; Sood A; Paddy MR; Duim WC; Dennis MY; McAllister AK; Ori-McKenney KM; Gray JA; Olson DE
    Cell Rep; 2018 Jun; 23(11):3170-3182. PubMed ID: 29898390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychedelic-inspired approaches for treating neurodegenerative disorders.
    Saeger HN; Olson DE
    J Neurochem; 2022 Jul; 162(1):109-127. PubMed ID: 34816433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice.
    de la Fuente Revenga M; Zhu B; Guevara CA; Naler LB; Saunders JM; Zhou Z; Toneatti R; Sierra S; Wolstenholme JT; Beardsley PM; Huntley GW; Lu C; González-Maeso J
    Cell Rep; 2021 Oct; 37(3):109836. PubMed ID: 34686347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Psychedelics on Neuronal Physiology.
    Hatzipantelis CJ; Olson DE
    Annu Rev Physiol; 2024 Feb; 86():27-47. PubMed ID: 37931171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.
    Canal CE
    Handb Exp Pharmacol; 2018; 252():227-260. PubMed ID: 29532180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of psychedelics for the treatment of Alzheimer's disease and related dementias.
    Winkelman MJ; Szabo A; Frecska E
    Eur Neuropsychopharmacol; 2023 Nov; 76():3-16. PubMed ID: 37451163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis.
    Shafiee A; Arabzadeh Bahri R; Rafiei MA; Esmaeilpur Abianeh F; Razmara P; Jafarabady K; Amini MJ
    J Psychopharmacol; 2024 May; 38(5):425-431. PubMed ID: 38385351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurotrophic mechanisms of psychedelic therapy].
    Corne R; Mongeau R
    Biol Aujourdhui; 2019; 213(3-4):121-129. PubMed ID: 31829932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.
    de Vos CMH; Mason NL; Kuypers KPC
    Front Psychiatry; 2021; 12():724606. PubMed ID: 34566723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.
    Heresco-Levy U; Lerer B
    Mol Psychiatry; 2024 Jan; 29(1):146-152. PubMed ID: 37945694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.
    Moliner R; Girych M; Brunello CA; Kovaleva V; Biojone C; Enkavi G; Antenucci L; Kot EF; Goncharuk SA; Kaurinkoski K; Kuutti M; Fred SM; Elsilä LV; Sakson S; Cannarozzo C; Diniz CRAF; Seiffert N; Rubiolo A; Haapaniemi H; Meshi E; Nagaeva E; Öhman T; Róg T; Kankuri E; Vilar M; Varjosalo M; Korpi ER; Permi P; Mineev KS; Saarma M; Vattulainen I; Casarotto PC; Castrén E
    Nat Neurosci; 2023 Jun; 26(6):1032-1041. PubMed ID: 37280397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the 5-HT
    Cameron LP; Benetatos J; Lewis V; Bonniwell EM; Jaster AM; Moliner R; Castrén E; McCorvy JD; Palner M; Aguilar-Valles A
    J Neurosci; 2023 Nov; 43(45):7472-7482. PubMed ID: 37940583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalysts for change: the cellular neurobiology of psychedelics.
    Banks MI; Zahid Z; Jones NT; Sultan ZW; Wenthur CJ
    Mol Biol Cell; 2021 Jun; 32(12):1135-1144. PubMed ID: 34043427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.
    Aleksandrova LR; Phillips AG
    Trends Pharmacol Sci; 2021 Nov; 42(11):929-942. PubMed ID: 34565579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychedelics action and schizophrenia.
    Maćkowiak M
    Pharmacol Rep; 2023 Dec; 75(6):1350-1361. PubMed ID: 37899392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines.
    Cameron LP; Patel SD; Vargas MV; Barragan EV; Saeger HN; Warren HT; Chow WL; Gray JA; Olson DE
    ACS Chem Neurosci; 2023 Feb; 14(3):351-358. PubMed ID: 36630260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychedelics and Other Psychoplastogens for Treating Mental Illness.
    Vargas MV; Meyer R; Avanes AA; Rus M; Olson DE
    Front Psychiatry; 2021; 12():727117. PubMed ID: 34671279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.